Clinical trial · Observational
Clinical Utility of Intraoperative Parathyroid Scores System in Thyroidectomy
NCT03172312CI-TRIAL-00027945IPSScompletedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Ready to establish the Intraoperative Parathyroid Scores System (IPSS) for thyroidectomy and study the clinical value of Intraoperative Parathyroid Scores System for thyroidectomy.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Intraoperative Parathyroid Scores System | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Different range of thyroid surgery | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Total thyroidectomy
- description
- Patients need to do total thyroidectomy According to guidelines
- interventionNames
- Procedure: Different range of thyroid surgery
- label
- Hemithyroidectomy
- description
- Patients need to do Hemithyroidectomy According to guidelines
- interventionNames
- Procedure: Different range of thyroid surgery
Primary outcomes (4)
- measure
- transplantation Parathyroid Scores correlated with transplanted parathyroid function
- timeFrame
- 2014-2016
- description
- relation with transplantation Parathyroid Scores and transplanted parathyroid hormone
Eligibility
Eligibility (as posted)
- Sex
- All
- Maximum age
- 60 Years
Show eligibility criteria text
Inclusion Criteria: 1. postoperative pathology confirmed as thyroid papillary carcinoma; 2. for the first time to undergo thyroid surgery, no history of neck surgery and external radiotherapy; 3. preoperative serum calcium, parathyroid hormone levels were normal; 4. intraoperative and postoperative clinical data integrity, standardized follow-up patients; 5. parathyroid is a tumor violation. Exclusion Criteria: 1. serious underlying disease; 2. age greater than 60 years of age or combined with arteriosclerotic disease; 3. patients with postoperative loss; 4. patients with parathyroid disease.
References
Publications (0)
Data not yet available
No reference posted for this study.